North American Proton Radiotherapy Systems Market Research Report
- Report Code: PR 1000
- Publish Date: Upcoming
The North American proton radiotherapy systems market, mainly driven by the rapidly changing cancer treatment technology and the growing number of cancer patients, was valued at $106.6 million in 2013 and is expected to reach $122.1 million by 2018, at a CAGR of 2.7%.
The report analyzes the market in terms of 2 segments such as cyclotron for proton therapy, and synchrotron for proton therapy. These segments experienced a positive growth till 2012 owing to an increase in the cancer patient pool, and the increased awareness for procedures and sophisticated diagnostic techniques. With a market value of $91.3 million and $15.3 million respectively, the cyclotron and synchrotron segments have been contributing 86% and 14% of the total proton radiotherapy systems market.
In North America, the rising rates of cancer population have been driving the market growth. The market growth is significantly higher in North America because it is always inclined to the newer techniques, while comparatively slow-moving markets such as Europe and Japan are maturing with both old and new technologies. North America is the most dynamic, highly competitive, and largest market for proton radiotherapy systems, globally.
The prevalence of cancer worldwide is around 7.4 million (53%) in males and 6.7 million (47%) in females, giving a male-female ratio of 10:9. In 2012, there were an estimated 14.1 million new cases of cancer in the world. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US. Cancer remains the second most common cause of death in the US, accounting for nearly 1 of every 4 deaths.
The report also provides an extensive competitive landscaping of the leading companies operating in the proton radiotherapy systems market. The main companies extensively covered in this report are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, Covidien, Protom international Inc., and Mevion Medical Systems, Inc. Furthermore, the segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in the report.
Customization Options:
Along with the market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix, which gives a detailed comparison of product portfolio of each company, mapped at country and sub-segment levels
- End-user adoption rate analysis of the products (segment-wise and country-wise)
- A comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country-specific prevalence of prostate cancer, breast & female genital organs cancers, lung and pleura cancers, head & neck cancers, colorectal cancer, spine cancer, and brain cancer
- Country-specific patient pool of prostate cancer, breast & female genital organs cancers, lung and pleura cancers, head & neck cancers, colorectal cancer, spine cancer, and brain cancer
- Disease progression (pattern analysis)
Procedure Volume Data
- The number of prostate cancer, brain cancer, lung, and head and neck cancers surgeries performed annually in each country, tracked till sub-segment level
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of surgeons’ responses to market events and trends
- Surgeons’ opinions about products from different companies
- Surgeons’ qualitative inputs on epidemiology data
Brand/ Product Perception Matrix
- A comprehensive study of customers’ perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- An analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Pricing Trends
- Cost analysis of compact advance proton radiotherapy systems devices in various countries of the region
- Prostate cancer, brain cancer, lung, and head and neck cancers procedural investments in major countries of the region
Competitive Intelligence
- The company share analysis of the top players of the market in the region
- The crucial developments and strategies that companies inculcate in their portfolio
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American External Beam Radiotherapy Devices Market The North American External Beam Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $1427.1 million in 2013 and expected to be $1571.7 million by 2018, growing at a CAGR of 2.0%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as Compact Advanced Radiotherapy Systems, Proton Radiotherapy Systems and Electron emitting high energy linear accelerators (Linac).The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
|
|
European External Beam Radiotherapy Devices Market The European External Beam Radiotherapy Devices Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $702.5 million in 2013 and expected to be $784.3 million by 2018, growing at a CAGR of 2.2%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as Compact Advanced Radiotherapy Systems, Proton Radiotherapy Systems and Electron emitting high energy linear accelerators (Linac).The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
|
|
Asian External Beam Radiotherapy Devices Market The Asian External Beam Radiotherapy Devices Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $699.2 million in 2013 and expected to be $919.6 million by 2018, growing at a CAGR of 5.6%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as Compact Advanced Radiotherapy Systems, Proton Radiotherapy Systems and Electron emitting high energy linear accelerators (Linac).The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
